Our Products
QBx™ Technology
At the heart of many of Regenerex products is QBx™ technology. QBx™ is the active ingredient that down regulates the production of certain proteases and matrix metalloproteases, or MMPs, which are protein enzymes that are proven to impede the healing of a majority of chronic wounds. Approximately 80% of chronic wounds display elevated levels of proteases (including MMPs). Our proprietary system is able to heal 95% of chronic wounds in 90 days or less.
Regenerex Wound Closure Program
Regenerex delivers a complete chronic wound closure program for State, Federal, managed care organizations, and managed care provider groups. The program provides more predictable outcomes and cost savings through a capitated, value based contracts.
Accelerex
Accelerex products are commercially available for the treatment of a wide variety of chronic and acute wounds. Accelerex is a custom-designed, CE approved and pending FDA reapproval, unit-dose, sterile wound cream containing QBx™.
Accelerex Sterile Creams
>> Accelerex™
Accelerex Dressings
Xcellderma
Xcellderma™ products are over-the-counter (OTC) sterile wound creams effective for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds.
>> Xcellderma™
Protocol Products
Regenerex provides products to administer in treatment and as part of the Regenerex Wound Closure Program.
>> Wound Wash Enzymatic
>> Debridement Exudate
>> Management Dressings
>> Compression Dressings
>> Offloading Devices
